Sapereaude,
Ok, I think understand. The only reason I
Sapereaude,
Ok, I think understand. The only reason I ask is to me the only agreement that I would like to see is with ICON. A spinoff and they a get a piece of L & N and we get to own at least 80% of the spinoff DX company.
Then we get to collect on every test ordered for as many BP as we can get. I don't believe we'll get a single buyout offer for L for the money we "should" get and what GC is willing to accept. Also, I don't trust a single BP. I want returns, but I also want tests to help patients and families down the road.
I don't not want a single JV with a single BP. But that's just me.
And maybe it a language barrier thing, but if you don't know what a JV should look like you might want to read a bit up on them and what the affects could be.
I have been MORE THAN LUCKY to have traveled throughout. Italy. Florence this time of year Is near heaven for me!!! For many years of my life, that would be the place I could live a blink of an eye. But now, Maui is more my path.
If we get the agreements I'm thinking about, I will buy you the Espresso!
Many many returns, CinCin
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...
Continue Reading
A Solid Performance from Piramal Pharma The numbers are in, and it's looking pretty good for Piramal Pharma Limited this time around. Their second quarter of fiscal year 2027 has seen some fireworks, and I'm not talking about some half-baked confetti deal. We're talking genuine growth and solid metrics here. Revenue and Profit Surge The headline? Revenue jumped a whopping...
Continue Reading
Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...
Continue Reading
A Rough Tumble for DICK'S Sporting Goods Let's cut to the chase: DICK'S Sporting Goods, Inc. (NYSE:DKS) just took a nosedive. We're talking a hard 30.68% fall on the stock, plummeting to $124.31 a share as of August 25, 2026. Now, if you were caught up in this whirlwind as an investor, you'd be forgiven for having a few choice words for the powers that be over at DICK'S....
Continue Reading
Judging by the latest buzz from La Vida's 2026 survey, the golden ticket for many US investors isn't a hot stock but something far more unexpected: the coveted 'Golden Visa.' Out of over 5,000 wealthy individuals invited to participate, 94.3% are mulling over a second residency or citizenship, and the big trigger? Political concerns. It's a clear sign that plenty of...
Continue Reading
What's Brewing at GeneDx? Looks like GeneDx Holdings Corp. is in some hot water—at least that's what Halper Sadeh LLC seems to think. Not your regular Tuesday at the exchange, folks. This legal eagle outfit is poking around GeneDx's henhouse, signaling possible breaches of fiduciary duties by their officers and directors. It's like catching a whiff of something fishy...
Continue Reading
BNY's CFO to Unpack Strategies at BMO Financials Conference They say you can tell a lot about a company by the folks steering the ship. And let me tell you, folks, Dermot McDonogh from BNY is setting sail over to Boca Raton to spill some beans. November 9 marks the date when BNY’s Chief Financial Officer will stand behind the mic at the BMO Financials Conference at 8:45...
Continue Reading
New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...
Continue Reading
New Beginnings with Signature Wealth There's a fresh breeze blowing through Signature Wealth's Greenville office, and its name is Jennifer Sharp. Now, if you're meandering through financial landscapes, Sharp is the guide you didn’t know you needed—until now. With nearly 20 years under her belt, she brings a wealth of experience coupled with a knack for handling life's...
Continue Reading
The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...
Continue Reading
Top 5 Most Recently Viewed Articles
Nvidia Raises Concerns Over Legislative Changes NVIDIA Corp. (NASDAQ: NVDA) has expressed significant concerns regarding proposed legislation in Congress, which aims to limit its ability to sell chips globally. This comes in the wake of a recent export agreement between President Trump and NVIDIA that allows chip sales to China. The company argues that the new legislative...
Continue Reading
Olin Corporation Offers Updated Outlook for Fourth Quarter Olin Corporation (NYSE: OLN) has provided insights regarding its performance for the fourth quarter of 2025, indicating a significant deviation from its previous expectations. The latest forecast suggests an adjusted EBITDA of nearly $67 million, a notable decrease from the earlier anticipated range of $110 to...
Continue Reading
Raising Standards in Business Process Outsourcing Innovature BPO is making headlines with the recent appointment of Thoai Nguyen as Chief Operating Officer. This strategic decision reflects the company's ambition to enhance its operational effectiveness and continue providing exceptional service in outsourcing. With a commitment to integrating AI-driven solutions,...
Continue Reading
TCL and F-Secure Forge a Strategic Partnership TCL, renowned for its innovations in display technology, has recently proclaimed a robust alliance with F-Secure, a leader in cybersecurity. This strategic collaboration was unveiled during Network X 2025 and aims to bolster the security features in TCL's products across Fixed Broadband (FBB), Fixed Wireless Access (FWA), and...
Continue Reading
Introduction to the Aromatherapy Accessory In today's fast-paced world, finding ways to unwind and relax is essential for maintaining overall well-being. What if you could enjoy the calming effects of aromatherapy while staying cool? An innovative inventor from Crown Point, Indiana, set out to create a solution that combines the benefits of aromatherapy with the...
Continue Reading